Pancreatin enteric tablets p/o 25 ED №10×6

Name Pancreatin enteric tablets p / o 25 ED No. 10×6 Active ingredients Pancreatin Release form 60 pcs. – dark glass jars (1) – cardboard packs. Dosage form Enteric-coated tablets Ingredients 1 tab. pancreatin 25 units Pharmacotherapeutic group digestive enzyme agent It has a proteolytic, amylolytic and lipolytic effect. It has a protective shell that does not dissolve before entering the small intestine, which protects the enzymes from the destructive action of gastric juice. Promotes rapid and complete digestion of food, eliminates symptoms resulting from indigestion (a feeling of heaviness and fullness in the stomach, flatulence, a feeling of lack of air, shortness of breath due to the accumulation of gases in the intestines, diarrhea). Improves the process of digestion of food in children; stimulates the secretion of its own enzymes of the pancreas, stomach and small intestine, as well as bile. Bile extract acts choleretically, promotes emulsification of fats, increases the activity of lipase, improves the absorption of fats and fat-soluble vitamins A, E, K. Hemicellulase is an enzyme that promotes the breakdown of plant fiber. – dystrophic diseases of these organs, condition after resection or irradiation); flatulence, diarrhea of non-infectious genesis; cystic fibrosis. To improve the digestion of food in people with normal gastrointestinal function in case of nutritional errors (eating fatty foods, large amounts of food, irregular meals); with violations of the chewing function (damage to the teeth and gums, during the period of getting used to the artificial jaw); sedentary lifestyle; prolonged immobilization. Preparation for x-ray examination and ultrasound of the abdominal organs. As an auxiliary drug for the speedy absorption of certain drugs (PASK, sulfonamides, antibiotics). Contraindications Hypersensitivity; hyperbilirubinemia; acute pancreatitis, chronic pancreatitis (exacerbation), hepatitis, liver failure, hepatic coma or precoma, gallbladder empyema, cholelithiasis, obstructive jaundice, intestinal obstruction. With caution: cystic fibrosis, pregnancy; children’s age (up to 3 years). Dosage and administration Inside, 1 dragee (an enteric-coated tablet) 3 during or immediately after a meal. Swallowed whole, not chewed. If necessary, a single dose is increased by 2 times. The duration of treatment is from several days (in case of indigestion due to nutritional errors) to several months and years (if constant replacement therapy is necessary). Before X-ray examination and ultrasound – 2 tablets 2-3 2-3 days before the study. Side effects Allergic reactions (skin flushing, sneezing, lacrimation), diarrhea, nausea, abdominal pain (including intestinal colic), hyperuricemia, hyperuricosuria. In children (when taken in high doses) – perianal irritation, irritation of the mucous membrane of the cavity mouth. Overdose Symptoms: hyperuricemia and hyperuricuria. Treatment: drug withdrawal, symptomatic therapy. Drug interaction Reduces the bioavailability of iron preparations Increases the absorption of PAS, sulfonamides, antibiotics. Cimetidine enhances the effect of the drug. Antacids containing magnesium and / or calcium ions reduce the effectiveness of the drug. Storage temperaturefrom 2℃ to 25℃ Buy Pancreatin enteric tablets p/o 25 U №10×6